FDA Approves NEXIUM(R) I.V. (Esomeprazole Sodium) For The Treatment Of GERD With Erosive Esophagitis In Pediatric And …
AstraZeneca (NYSE: AZN) announced today that the U.S. Food and Drug Administration (FDA) has approved the use of NEXIUM® I.V. (esomeprazole sodium) for Injection for children ages greater than 1 month old for the short-term treatment of gastroesophageal reflux disease (GERD) with erosive esophagitis when oral therapy is not possible or appropriate.1 NEXIUM I.V. is the first proton pump inhibitor …
Read more on Medical News Today
Second Opinion: Nighttime eating might be a disorder
Night Eating Syndrome affects approximately 1 percent to 2 percent of the population. Both men and women are affected.
Read more on The Milford Daily News